Alcohol-induced hyperlipidemia is ameliorated by orally administered DWP208, a sodium succinate form of ZYM201

Korean Journal of Physiology and Pharmacology

Volumn 18, Issue 6, 2014, Pages 469-474

  Cho, Jae Youl ^a   Choi, Jongwon ^b   Park, Jae Gwang ^a   Yi, Young Su ^a   Hossen, Muhammad Jahangir ^a,c   Kim, Hyeongmin ^d   Ro, Jieun ^d   Cha, Bae Cheon ^e   Yoo, Eun Sook ^f   Kim, Jong Hoon ^g   Lee, Jaehwi ^d  

^a Sungkyunkwan University   (South Korea)

^b Kyungsung University   (South Korea)

^c PATUAKHALI SCIENCE AND TECHNOLOGY UNIVERSITY   (Bangladesh)

^d Chung Ang University   (South Korea)

^e Sangji University   (South Korea)

^f Jeju National University School of Medicine   (South Korea)

^g Chonbuk National University   (South Korea)

Author keywords

Anti hyperlipidemic activity; Chronic alcohol treatment; DWP208; Sanguisorba officinalis; Triterpenoid glycoside

Indexed keywords

ALCOHOL; DWP 208; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; SUCCINIC ACID; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TRITERPENOID; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; ZYM 201;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ENZYME ACTIVITY; HYPERLIPIDEMIA; LIPID DIET; LIPID METABOLISM; MALE; NONHUMAN; RAT; SANGUISORBA; SANGUISORBA OFFICINALIS; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

EID: 84921533098     PISSN: 12264512     EISSN: 20933827     Source Type: Journal    
DOI: 10.4196/kjpp.2014.18.6.469     Document Type: Article

References (30)

1. Maxwell JC. Update: comparison of drug use in Australia and the United States as seen in the 2001 National Household Surveys. Drug Alcohol Rev. 2003;22:347-357.
2. Thomson SJ, Westlake S, Rahman TM, Cowan ML, Majeed A, Maxwell JD, Kang JY. Chronic liver disease-an increasing problem: a study of hospital admission and mortality rates in England, 1979-2005, with particular reference to alcoholic liver disease. Alcohol Alcohol. 2008;43:416-422.
3. You M, Crabb DW. Recent advances in alcoholic liver disease II. Minireview: molecular mechanisms of alcoholic fatty liver. Am J Physiol Gastrointest Liver Physiol. 2004;287:G1-6.
4. Arteel GE, Iimuro Y, Yin M, Raleigh JA, Thurman RG. Chronic enteral ethanol treatment causes hypoxia in rat liver tissue in vivo. Hepatology. 1997;25:920-926.
5. Albano E. Oxidative mechanisms in the pathogenesis of alcoholic liver disease. Mol Aspects Med. 2008;29:9-16.
6. Deaciuc IV, Doherty DE, Burikhanov R, Lee EY, Stromberg AJ, Peng X, de Villiers WJ. Large-scale gene profiling of the liver in a mouse model of chronic, intragastric ethanol infusion. J Hepatol. 2004;40:219-227.
7. Chait A, Mancini M, February AW, Lewis B. Clinical and metabolic study of alcoholic hyperlipidaemia. Lancet. 1972;2:62-64.
8. Lefevre AF, De Carli LM, Lieber CS. Effect of ethanol on cholesterol and bile acid metabolism. J Lipid Res. 1972;13:48-55.
9. Cho JY, Yoo ES, Cha BC, Park HJ, Rhee MH, Han YN. The inhibitory effect of triterpenoid glycosides originating from Sanguisorba officinalis on tissue factor activity and the production of TNF-alpha. Planta Med. 2006;72:1279-1284.
10. Asao Y, Morikawa T, Xie Y, Okamoto M, Hamao M, Matsuda H, Muraoka O, Yuan D, Yoshikawa M. Structures of acetylated oleanane-type triterpene saponins, rarasaponins IV, V, and VI, and anti-hyperlipidemic constituents from the pericarps of Sapindus rarak. Chem Pharm Bull (Tokyo). 2009;57:198-203.
11. Liu SJ, Ramsey RK, Fallon HJ. Effects of ethanol on hepatic microsomal drug-metabolizing enzymes in the rat. Biochem Pharmacol. 1975;24:369-378.
12. Yuan Q, Shi H. Treatment of hyperlipemia by acupoint catgutembedding in 34 cases. J Tradit Chin Med. 2003;23:208.
13. Takahashi T, Hirano T, Okada K, Adachi M. Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice. Metabolism. 2003;52:1354-1359.
14. Sagone AL Jr, Decker MA, Wells RM, Democko C. A new method for the detection of hydroxyl radical production by phagocytic cells. Biochim Biophys Acta. 1980;628:90-97.
15. Giada F, Baldo-Enzi G, Balocchi MR, Zuliani G, Baroni L, Fellin R. Heparin-released plasma lipase activities, lipoprotein and apoprotein levels in young adult cyclists and sedentary men. Int J Sports Med. 1988;9:270-274.
16. Fraga CG, Leibovitz BE, Tappel AL. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic Biol Med. 1988;4:155-161.
17. Wahlund G, Marklund SL, Sjoquist PO. Extracellular-superoxide dismutase type C (EC-SOD C) reduces myocardial damage in rats subjected to coronary occlusion and 24 hours of reperfusion. Free Radic Res Commun. 1992;17:41-47.
18. Ametaj BN, Bobe G, Lu Y, Young JW, Beitz DC. Effect of sample preparation, length of time, and sample size on quantification of total lipids from bovine liver. J Agric Food Chem. 2003;51:2105-2110.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248-254.
20. Choi J, Kim MY, Cha BC, Yoo ES, Yoon K, Lee J, Rho HS, Kim SY, Cho JY. ZYM-201 sodium succinate ameliorates streptozotocin-induced hyperlipidemic conditions. Planta Med. 2012;78:12-17.
21. Grauvogel J, Daemmrich TD, Ryschich E, Gebhard MM, Werner J. Chronic alcohol intake increases the severity of pancreatitis induced by acute alcohol administration, hyperlipidemia and pancreatic duct obstruction in rats. Pancreatology. 2010;10:603-612.
22. Wang Z, Yao T, Song Z. Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver. Alcohol Clin Exp Res. 2010;34:471-478.
23. Vinik AI. The metabolic basis of atherogenic dyslipidemia. Clin Cornerstone. 2005;7:27-35.
24. Albano E. Alcohol, oxidative stress and free radical damage. Proc Nutr Soc. 2006;65:278-290.
25. Hiramatsu M, Edamatsu R, Mori A. Free radicals, lipid peroxidation, SOD activity, neurotransmitters and choline acetyltransferase activity in the aged rat brain. EXS. 1992;62:213-218.
26. Liu ZQ, Luo XY, Liu GZ, Chen YP, Wang ZC, Sun YX. In vitro study of the relationship between the structure of ginsenoside and its antioxidative or prooxidative activity in free radical induced hemolysis of human erythrocytes. J Agric Food Chem. 2003;51:2555-2558.
27. Liu TZ, Lee KT, Chern CL, Cheng JT, Stern A, Tsai LY. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappaB. Ann Clin Lab Sci. 2001;31:383-390.
28. Wang P, Niu L, Guo XD, Gao L, Li WX, Jia D, Wang XL, Ma LT, Gao GD. Gypenosides protects dopaminergic neurons in primary culture against MPP (+) -induced oxidative injury. Brain Res Bull. 2010 30;83:266-271.
29. Ying-Wan, Wu YL, Feng XC, Lian LH, Jiang YZ, Nan JX. The protective effects of total saponins from Ornithogalum saundersiae (Liliaceae) on acute hepatic failure induced by lipopolysaccharide and D-galactosamine in mice. J Ethnopharmacol. 2010;132:450-455.
30. Rujjanawate C, Kanjanapothi D, Amornlerdpison D. The antigastric ulcer effect of Gynostemma pentaphyllum Makino. Phytomedicine. 2004;11:431-435.